Kentucky Cabinet for Health and Family Services (Banner Imagery) - Go to home page

Archived Pharmacy Announcements

Attention Department for Medicaid Services  providers/partners

The Department for Medicaid Services is aware of issues with the new benefind system, which processes all benefit programs administered by the Department for Community Based Services. It has resulted in discontinuation letters being sent in error or the system incorrectly showing an individual as ineligible. The Cabinet for Health and Family Services is taking action to ensure that no individual loses benefits as a result. If a person was eligible for Medicaid benefits in March, the person will automatically be eligible for benefits in April.

The Cabinet and DCBS are working with their technology partner, Deloitte, on system issues to stop the incorrect notices and properly reflect eligibility. Medicaid requests that providers continue to provide necessary services and prescriptions to members during this time.

Kentucky Drug Utilization Review Annual Reports Online

(June 2014) - States are required to submit annual Drug Utilization Review (DUR) annual reports on prescribing habits, DUR program cost savings and program operations, including adoption of new DUR practices based on responses to the Medicaid Drug Utilization Review Annual Report survey. For more information about the Kentucky DUR survey, please visit CMS Medicaid Drug Programs Data and Resources website. Follow the instructions to select DUR and Kentucky to view all available online reports.

Attention Kentucky Medicaid Members: New warnings about the use of Acetaminophen (Tylenol)

On Aug. 1, 2013, the Food and Drug Administration issued a warning that acetaminophen (name brands include Tylenol) products may cause serious skin reactions. Prescription medications containing acetaminophen, over-the-counter medications containing acetaminophen, products containing only acetaminophen and products containing acetaminophen in combination with other medications may cause serious skin reactions. These skin reactions may cause reddening of the skin, rash, blisters and detachment of the upper surface of the skin. These reactions could be life threatening. If you have a skin reaction and you are taking acetaminophen, stop taking the medicine immediately and call your doctor.

To help prevent the potential for serious liver disease, members are encouraged to keep their daily dose of acetaminophen to no more than 3,000 mg per day.

Return to the top of the page.

Makena® Coverage Change

Beginning Oct. 2, 2013, we will begin covering Makena® for our fee-for-service recipients with prior authorization approval. Please refer to the Fee-For-Service Pharmacy Provider Notice #167 - July Pharmacy Updates for additional information.

Older Announcements

  • National Prescription Drug Toss - Saturday, Oct. 26, 2013 -The Drug Enforcement Administration has designated Saturday, Oct 26, 2013, from 10 a.m. - 2 p.m. a drug take-back day. The National Prescription Drug Take-Back Day provides safe, convenient and responsible prescription drug disposal and educates the public about the potential for medication abuse. According to a recent report by the Trust for America's Health, Kentucky has the third-highest rate of fatal overdoses. The majority of these deaths are from prescription medications. More than 70 prescription drug collection sites in Kentucky currently are scheduled to be open on Saturday, Oct. 26, from 10 a.m. - 2 p.m. for drug tossing. Find a drug disposal location in your area. We hope Kentuckians will participate in this event and help rid Kentucky of the potential harm from unnecessary prescription drugs.
  • Notice regarding Omontys Recall - 02/24/2013: FDA is alerting health care providers and patients of a voluntary nationwide recall of ALL lots of Omontys Injection by Affymax and Takeda Pharmaceuticals. The recall is due to reports of anaphylaxis, some fatal. Omontys is used to treat anemia in adult dialysis patients. Until further notice, health care providers should stop using Omontys and return the product to Takeda. For details, please visit the FDA page and the Takeda/Affymax News Release.
  • Announcement - 5010 D.O Information -Please be advised that the Department for Medicaid Services and the Magellan Medicaid Administration will be transitioning from NCPDP Version 5.1 to NCPDP Version D.0 in the Kentucky Medicaid Pharmacy Program on Jan. 1, 2012. Updates
  • Announcement 2009-2010 RSV Season- Sept. 1, 2009 - The Department for Medicaid Services has made a change in policy related to the use of Synagis®. The department will closely follow the new recommendations from the American Academy of Pediatrics for the appropriate utilization of Synagis® for the prevention of respiratory syncytial virus (RSV). As a result, the 2009 RSV season will begin Nov. 1, 2009 and continue through March 31, 2010. Synagis Flyer , Provider Notice for Synagis, Synagis Prior Authorization Request Form
  • 4 Rx Member Letter
  • Pharmacy Provider Letter - Pharmaceutical Reimbursement (April 19, 2005)
  • Dispensing and Acquisition Costs of Pharmaceuticals in the Commonwealth of Kentucky
  • Pharmacy POS Implementation
  • Important Information regarding Medicaid's Payment Cycle (April 17, 2007)
  • Important information regarding Tier 3 Pharmacy Co-payment (Sept. 25, 2006)
NPI Information

Announcement - National Provider Identifier (NPI) - Final Implementation Date

Oct. 8, 2008

This notice serves as a final reminder that submission of the prescriber's NPI on all pharmacy prescription claims is mandated for Kentucky Medicaid patients.

Click on the National Provider Identifier (NPI) - Final Implementation Date for more information.

National Provider Identifier Information

Pharmacy Provider Letter #A-477 - Submitting NPI and Taxonomy Codes to KyHealth Choices (03/20/07)

For more information on submitting your NPI and taxonomy code(s):

Tamper-Resistant Prescription Pads


See Also
  Pharmacy Program Page  

Archived Advisory Committee Information

Last Updated 2/22/2018